# Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load

> **NCT00973219** · NA · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 151 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate

## Key facts

- **NCT ID:** NCT00973219
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2019-10
- **Final completion:** 2019-10
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2021-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00973219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00973219, "Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00973219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*